D-0363-2025 Class II Ongoing
FDA drug recall D-0363-2025 was initiated by Eugia US LLC on Apr 10, 2025 and is designated Class II. Reason for recall: cGMP: complaints of crystals not redissolving into solution after warming and shaking the vials. The recall status is ongoing. Affected quantity: 36,816 vials.
Recall details
- Product Type
- Drugs
- Report Date
- Apr 23, 2025
- Initiation Date
- Apr 10, 2025
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 36,816 vials
Product description
Testosterone Cypionate Injection, USP, CIII, 200mg per mL, Rx only, 1mL Single-Dose Vial, Distributed by Eugia US LLC, E. Windsor, NJ, Manufactured by: Eugia Specialties Limited, Telangana State, India, NDC 55150-277-01
Reason for recall
cGMP: complaints of crystals not redissolving into solution after warming and shaking the vials.
Distribution pattern
Nationwide USA
Code information
Lot #: 1TC24075A, Exp 11/30/2026.
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0363-2025
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026